Catalyst Wire Dossier Catalyst Wire Dossier

NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins)

Botulinum neurotoxin type A free of complexing proteins · Merz Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins), covering 2015-03-30 to 2015-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders [Phase 2]

See pricing